Intracapsular Tonsillectomy in Adults

Sponsor
Turku University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03654742
Collaborator
(none)
200
1
3
99.1
2

Study Details

Study Description

Brief Summary

Comparing the classical extracapsular tonsillectomy (TE) performed with electrosurgery to intracapsular approaches (SIPT) by coblation or microdebrider. The patient group is adults with recurrent or chronic tonsillitis

Condition or Disease Intervention/Treatment Phase
  • Procedure: tonsillectomy
N/A

Detailed Description

Extracapsular tonsillectomy (TE) with monopolar electrosurgery is the most commonly used approach in adult tonsil surgery in Turku University Central Hospital, Finland.

In our study setting we are comparing intracapsular tonsillectomy (subtotal/intracapsular/partial tonsillectomy (SIPT) ) as the intervention group with extracapsular tonsillectomy as the control group.

SIPT is done with either coblation or microdebrider and TE with monopolar electrosurgery.

Indications for surgery are recurrent tonsillitis or chronic tonsillitis. The patient group is adults (16-65 years)

Safety, efficiency and cost-effectiveness are monitored in a prospective, patient-blinded and randomised study setting.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
prospective, single-blinded, randomised, controlledprospective, single-blinded, randomised, controlled
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Patients are masked with numbers and patient records not shown to the outcomes assessor
Primary Purpose:
Treatment
Official Title:
Intracapsular vs Extracapsular Tonsillectomy. A Comparison of Treatment Methods of Recurrent and Chronic Tonsillitis in Adults: a Prospective Single-blinded Randomised Study
Actual Study Start Date :
Sep 27, 2019
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 30, 2027

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ECTE/Electrosurgery

Extracapsular tonsillectomy (ECTE) with monopolar electrosurgery

Procedure: tonsillectomy
removal of tonsil tissue as described in the study arms
Other Names:
  • tonsil removal
  • tonsil surgery
  • Experimental: ICTE/Microdebrider

    Intracapsular tonsillectomy (ICTE) with microdebrider

    Procedure: tonsillectomy
    removal of tonsil tissue as described in the study arms
    Other Names:
  • tonsil removal
  • tonsil surgery
  • Experimental: ICTE/Coblator

    Intrapsular tonsillectomy (ICTE) with coblator

    Procedure: tonsillectomy
    removal of tonsil tissue as described in the study arms
    Other Names:
  • tonsil removal
  • tonsil surgery
  • Outcome Measures

    Primary Outcome Measures

    1. Post-operative recovery [21 days]

      Pain post-operatively after discharge as self-reported pain intensity over the past day. Each day is scored with the modified Brief Pain Inventory and recovery is achieved when pain score reaches preset values. Recovery speed defined as pain VAS-score 3 or less at rest; or pain VAS-score 5 or less without regular analgesics use. Daily questionnaire used: Brief Pain Inventory.

    Secondary Outcome Measures

    1. Analgesics use [21 days]

      Need for analgesics postoperatively during 21 days. Measured as number of naprometin tablets/ day and the number of tramadol-paracetamol combination tablets/day.

    2. Post-operative bleeding [21 days]

      Bleeding post-operatively at the ward or at any point during 21 days. Measured as 1-4 (1= bleeding, stopped spontaneously, no contact with staff; 2: Contact with ER, bleeding stopped without intervention; 3: Bleeding, needed intervention (packing, topical adrenalin, electrosurgical hemostasis; 4: Needed OR-time, blood transfusion, ward days

    3. Life Quality [6 months]

      Quality of life as defined by the questionnaires: Tonsillectomy Outcome Inventory 14 "TOI-14" preoperatively and 6 months after operation;

    4. Residual tonsil tissue [6 months]

      Residual tonsil measured right after surgery is completed and at 6 months follow-up.

    5. Revision surgery [5 years]

      The need of revision surgery after tonsillectomy, recorded with questionnaire: Nordic Tonsil Surgery Register

    6. Throat problems [5 years]

      Throat problems as described by the Nordic Tonsil Surgery Register at different time points postoperatively

    7. Life quality [6 months]

      Quality of life as defined by the questionnaires: Glasgow Benefit Inventory "GBI" at 6 months after operation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 16-65 years

    • Planned tonsil surgery with informed consent

    • Recurrent or chronic tonsillitis

    Exclusion Criteria:
    • Less than 1 month old, drained quinsy

    • Acute "hot phase" tonsillitis

    • Previous palatine tonsil surgery

    • Suspicion or confirmation of malignancy

    • High dose analgesics consumption

    • Current CPAP-device usage for treatment of OSAS

    • Untreated gastro-esophageal reflux disease

    • Anticoagulative medication

    • Any condition of hemophilia

    • Pregnancy, lactation

    • Current or positive history of malignant disease (if still active follow-up)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 TYKS Korvaklinikka Turku Finland 20521

    Sponsors and Collaborators

    • Turku University Hospital

    Investigators

    • Study Director: Jussi Jero, Professor, Turku University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jaakko Piitulainen, Consultant, Turku University Hospital
    ClinicalTrials.gov Identifier:
    NCT03654742
    Other Study ID Numbers:
    • T211/2018
    First Posted:
    Aug 31, 2018
    Last Update Posted:
    Aug 11, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jaakko Piitulainen, Consultant, Turku University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 11, 2022